HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals

Nature Medicine

Volumn 3, Issue 11, 1997, Pages 1250-1257

  Mazzoli, Sandra ^a   Trabattoni, Daria ^b   Lo Caputo, Sergio ^a   Piconi, Stefania ^c   Blé, Claudio ^a   Meacci, Francesca ^a   Ruzzante, Stefania ^b   Salvi, Alessanda ^a   Semplici, Francesca ^a   Longhi, Renato ^d   Fusi, Maria Luisa ^b   Tofani, Nadia ^a   Biasin, Mara ^b   Villa, Maria Luisa ^b   Mazzotta, Francesco ^a   Clerici, Mario ^b  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 2; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RESISTANCE; MALE; PRIORITY JOURNAL; SEROLOGY; VIRUS DETECTION; VIRUS INFECTIVITY;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030702772     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1197-1250     Document Type: Article

References (54)

1. Levy, J.A. HIV pathogenesis and long-term survival. AIDS 7, 1401-1418 (1993).
2. Rowland-Jones, S.L. & McMichael, A. Immune responses in HIV-exposed seronegatives: Have they repelled the virus? Curr. Opin. Immunol. 7, 448-455 (1995).
3. Shearer, G.M. & Clerici, M. Protective immunity against HIV infection: Has nature done the experiment for us? Immunol. Today 17, 21-24 (1996).
4. Clerici, M. et al. Cell mediated immune response to human immunodeficiency virus type 1 (HIV-1) in seronegative homosexuals with recent sexual exposure to HIV-1. J. Infect. Dis. 165, 1012-1019 (1992).
5. Rowland-Jones, S. L. et al. HIV-specific cytotoxic T cell activity in an HIV exposed but uninfected infant. Lancet 341, 860-861 (1993).
6. Clerici, M. et al. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 7, 1427-1433 (1993).
7. De Maria, A., Cirillo, C. & Moretta, L. Occurrence of HIV-1 specific cytolytic T cell activity in apparently uninfected children born to HIV-1 infected mothers. J. Infect. Dis. 170, 1296-1299 (1994).
8. Cheynier, R. et al. Cytotoxic T lymphocyte response in peripheral blood of children born to HIV-infected mothers. Eur. J. Immunol. 22, 2211-2217 (1994).
9. Clerici, M. et al. HIV-specific T helper activity in HIV seronegative health care workers accidentally exposed to HIV-contaminated blood. JAMA 271, 42-46 (1994).
10. Pinto, L. et al. Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest. 96, 867-876 (1995).
11. Rowland-Jones, S. L. et al. HIV-specific cytotoxic T cells in HIV-exposed but uninfected Gambian women. Nature Med. 1, 59-64 (1995).
12. Fowke, K.R. et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348, 1347-1351 (1996)
13. Ranki, A.M. et al. T cell responses to HIV in infected individuals with and without Zidovudine therapy and in HIV exposed sexual partners. AIDS 3, 83-89 (1989).
14. Langlade-Demoyen, P., Ngo-Giang-Huong, F., Ferchal, F. & Oksenhendler, E. HIV-nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV infected patients. J. Clin. Invest. 93, 1297-1297 (1994).
15. Cocchi, F. et al. Identification of RANTES, MIP-1a, MIP-1b as the major HIV-suppressive factors produced by CD8 T cells. Science 270, 1811-1815 (1995).
16. Paxton W.A. et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med 2, 412-417 (1995).
17. Lehner, T. et al. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Med. 2, 767-775 (1995).
18. Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377 (1996).
19. Henderson, D.K. et al. Risk for occupational transmission of HIV-1 associated with clinical exposure: A prospective evaluation. Ann. Int. Med. 113, 740-746 (1990)
20. European Collaborative Study. Children born to women with HIV-1 infection: Natural history and risk of transmission. Lancet 337, 253-260 (1991)
21. World Health Organization. AIDS 4, Global Data. Weekly Epidemiol. Rec. 70, 5-12 (1995).
22. Alexander, N. Sexual transmission of human immunodeficiency virus: Virus entry into the male and female genital tract. Fert. Ster. 54, 1-18 (1990).
23. Miller, C.J., McGhee, J.R & Gardner, M.B. Mucosal immunity, HIV transmission and AIDS. Lab. Invest. 68, 129-145 (1992).
24. Staats, H.F. & McGhee, J.R. Mucosal immunity in HIV infection. in: Immunology of HIV Infection. pag. 387-416. S. Gupta Ed. Plenum Press, N.Y., N.Y. (1996).
25. Zeitz, M., Schneider, T. & Ullrich, R. Mucosal HIV Infection: A paradigm for dysregulation of the mucosal immune system. in Essentials of Mucosal Immunology. pag. 421-436. Academic Press Inc, N.Y., N.Y. (1996).
26. Lehner, T. et al. Genital and rectal mucosal immunity against transmission of SIV/HIV. in Essentials of Mucosal Immunology. pag. 437-447. Academic Press Inc, N.Y., N.Y. (1996).
27. Urnovitz, H.B. et al. HIV-1 antibody serum negativity with urine positivity. Lancet 342, 1458-1459 (1993).
28. Urnovitz, H. B., Murphy, W. H., Gottfried, T. D. & Friedman-Kien, A. E. Urine-Based Diagnostic Technologies. Trends Biotech. 14, 361-364 (1996).
29. Belec, L., Tevi-Benissan, C., Gresenguet, G., Meillet, D. & Pillot, J. HIV-1 antibody serum negativity with vaginal secretions positivity. Lancet 343, 1046-1047 (1994).
30. Giorgi, J. V. et al. Early effects of HIV on CD4 lymphocytes in vivo. J. Immunol. 138, 3725-3730 (1987).
31. Clerici, M. et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J. Clin. Invest. 84, 1892-1899 (1989).
32. Clerici, M. & Shearer, G.M. The TH1/TH2 hypothesis of HIV infection: New insights. Immunol. Today 15, 575-581 (1994).
33. Baggiolini, M., Dewald, B & Moser, B. The biology of chemokines. Adv. Immunol. 55, 97-179 (1994).
34. Mc Kenzie, S.W. Serum chemokine levels in patients with non-progressing HIV infection. AIDS 10, 29-33 (1996).
35. Clerici, M. et al. Chemokines production in HIV-seropositive patients with different patterns of disease progression. AID 10, 1432-1433 (1996).
36. Levy, J.A., Mackewicz, C.E. & Barker, E. Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol. Today 17, 217-224 (1996).
37. Mazzoli, S. et al. Clinical consequences of immune responses to Chlamydia in men. Infect. Dis. Obstet. Cynecol. 4, 136-142 (1996)
38. Turner, V. Is a positive western blot proof of HIV infection? BioTechnology 11, 696-670 (1993).
39. Mazanec, M.B., Kaetzel, C.S., Lamm, M.E., Fletcher, D. & Nedrud, J.C. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA 89, 6901-6905 (1992).
40. Emilie, D., Maillot, M.C., Nicolas, J.F., Fior, R. & Galanaud, P. Antagonistic effect of IFN gamma on tat-induced transactivation of HIV by long terminal repeat. J. Biol. Chem. 267, 20565-20570 (1992).
41. Stoiber, H., Pinter, C., Siccardi, A.G., Clivio, A. & Dierich, M.P. Efficient destruction of HIV in human serum by inhibiting the protective action of complement factor Hand decay-accelerating factor (DAF, CD55). J. Exp. Med. 183, 307-310 (1996).
42. Hilleman, M. Whether and when an AIDS vaccine? Nature Med. 1, 1126-1129 (1995).
43. Miller, J.C. & McGhee, J.R. Progress towards a vaccine to prevent sexual transmission of HIV. Nature Med. 2, 751-1752 (1996).
44. Murphey-Cobb, M. et al. A formalin inactivated whole SIV vaccine confers protection in macaques. Science 246, 1293-1297 (1989).
45. Carlson, J.R. et al. Vaccine protection of Rhesus macaques against SIV infection. AIDS Res. Hum. Retrovir. 6, 1239-1246 (1990).
46. Clerici, M. et al. T-cell proliferation to subinfectious doses SIV correlates with lack of infection after challenge of macaques. AIDS 8, 1391-1396 (1994).
47. Salvato, M.S. et al. Cellular immune responses in rhesus macaques infected rectally with low dose simian immunodeficiency virus. J. Med. Primatol. 23, 125-130 (1994).
48. Lehner, T. et al. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258, 1365-1369 (1992).
49. Bukawa, H. et al. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate. Nature Med. 1, 681-685 (1995).
50. Robert-Guroff, M. et al. Spectrum of HIV-1 neutralizing antibodies in a cohort of homosexual men: Results of a 6 year prospective study. AIDS Res. Hum. Retrovir. 4, 343-350 (1988).
51. Shafferman, A. et al. Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infection. AIDS Res. Hum. Retrovir. 5, 33-39 (1989).
52. Ugen, K.E. et al. Vertical transmission of human immunodeficiency virus (HIV) infection. Reactive of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. J. Clin. Invest. 89, 1923-1930 (1992).
53. Cease, K.B. et al. Helper T cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16 residues synthetic peptide. Proc. Nat. Acad. Sci. USA 84, 4249-4253 (1987).
54. Hale, P.M. et al. T cell multideterminant regions in HIV envelope: Toward overcoming the problem of major histocompatibility complex restriction. Int. Immunol. 1, 409-415 (1989).